The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 27, 2022
Filed:
Dec. 23, 2016
Polyquant Gmbh, Bad Abbach, DE;
Commissariat a L'energie Atomique ET Aux Energies Alternatives, Paris, FR;
Biomedical Research Foundation of the Academy of Athens, Athens, GR;
Luxembourg Institute of Health, Luxembourg, LU;
Institut Curie, Paris, FR;
Assistance Publique—hopitaux DE Paris, Paris, FR;
Fundacion Centro Nacional DE Investigaciones Oncologicas Carlos Iii, Cnio, Madrid, ES;
Jerome Garin, Paris, FR;
Christophe Masselon, Paris, FR;
Antonia Vlahou, Athens, GR;
Manousos Makrydakis, Athens, GR;
Ieronimos Zoidakis, Athens, GR;
Bruno Domon, Luxembourg, LU;
Elodie Duriez, Luxembourg, LU;
Aurelie Kamoun, Paris, FR;
Francois Radvanyi, Paris, FR;
Yves Allory, Paris, FR;
Nuria Malats Riera, Madrid, ES;
Mirari Marquez Cid, Madrid, ES;
Magali Court, Paris, FR;
POLYQUANT GMBH, Bad Abbach, DE;
COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, Paris, FR;
BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS, Athens, GR;
LUXEMBOURG INSTITUTE OF HEALTH, Luxembourg, LU;
INSTITUT CURIE, Paris, FR;
ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, Paris, FR;
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III, CNIO, Madrid, ES;
Abstract
The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.